Upgrade to SI Premium - Free Trial

Quest Diagnostics (DGX) PT, Estimates Raised at Evercore ISI Amid Solid Q2

July 21, 2016 12:00 PM
Evercore ISI analyst Ross Muken raised estimates and his price target on Quest Diagnostics (NYSE: DGX) to $89.50 (from $78.50) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles